COVID-19 Information for Sponsored Programs

During COVID-19, the Office of Sponsored Programs (OSP) plans to be fully operational.

The Office of Sponsored Programs (OSP) is currently fully operational. In response to the COVID-19 Pandemic, OSP will be working from home beginning March 16, 2020 until further notice. OSP staff continue to be available by email and phone, and our main line (412-624-7400) can also be used. Transaction requests and their related communications should continue to be sent through OSP electronic systems (MyFunding, MyRA, Contraxx, etc.)

For the latest updates from PittResearch, visit https://research.pitt.edu/pitt-researchers/research-operations-during-covid-19-pandemic. For all updates related to the University’s response to the COVID-19 pandemic, please visit www.emergency.pitt.edu/covid-19.

This page was last updated 01/13/2021 11:00 AM

 

OSP is monitoring the release of information related to COVID-19 from the University of Pittsburgh and from funding sponsors, including federal agencies. The information below will continue to be updated.

OSP Communications
E-mail regarding COVID-19 Information (released 03-12-2020) 

Pitt Research

Senior Vice Chancellor for Research Update on Research at Pitt (12-14-2020)
Office of Research Protections Important Update on Tier 3 Studies (11-24-2020)
​Senior Vice Chancellor for Research Update on Tier 3 Research Activities (11-23-2020)
Senior Vice Chancellor for Research Updated Details, Resources for Research Operations During the Pandemic (10-20-2020)
Senior Vice Chancellor for Research Research Restart website (06-10-2020)
Senior Vice Chancellor for Research Research Restart announcement (06-03-2020)
Senior Vice Chancellor for Research Guidelines for Essential Research Personnel  (released 03-25-2020)
Senior Vice Chancellor for Research Coordination of COVID-19 Research at Pitt and UPMC (released 03-23-2020)
Senior Vice Chancellor for Research COVID-19: Status of Clinical Research Operations at Pitt (released 03-16-2020)
Senior Vice Chancellor for Research Pandemic Preparedness Guide for Researchers (released 03-12-2020)
Senior Vice Chancellor for Research Important - Clinical Research operations and COVID-19 (released 03-11-2020)
Senior Vice Chancellor for Research Emergency Page (released 03-11-2020) 
Senior Vice Chancellor for Research COVID-19: Status of Research Operations at Pitt (released 03-11-2020)

University of Pittsburgh
Office of the Chancellor Our plans for being safe on campus (released 06-20-2020)
COVID-19 Update, confirmed case of coronavirus on campus (released 03-22-2020)
Office of Human Resources COVID-19 Workplace Concerns: Resources for Employees (released 03-18-2020)
​Office of the Chancellor A Reduction in Operating Status (released 03-18-2020)
Office of the Chancellor COVID-19 update for faculty and staff (released 03-14-2020)
Office of the Chancellor COVID-19 Pandemic: Pitt's Actions (released 03-10-2020)
Pitt OHR Information Regarding Travel Expense Reimbursement and COVID-19 (released 03-10-2020) 
Public Safety & Emergency Management’s COVID-19 information page (released 03-10-2020)
Pitt IT's Covid-19 Preparation Information (released 03-10-2020)

External Agencies

Funding Opportunities

Agency
Opportunity ID
Sponsor Due Date Posted
American Lung Association COVID-19 & Respiratory Virus Research Award 
LOI due on 02-18-2021

04-30-21

01-13.2021
BARDA BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement – COVID-19 Topics 02-03-2023 03-9-2020
CDMRP Helpdesk Pre-Application deadline extension for the CDMRP ALSRP, ARP and OCRP X 03-19-2020
Centers for Disease Control and Prevention (CDC) Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality 02-18-2021 11-09-2020
Center for Medicare and Medicaid Services (CMS) CMS Increases Medicare Payment for High-Production Coronavirus Lab Tests X 04-15-2020
Cisco RFP-20-04 Pandemic/COVID19 Science, Technology and Social Impact Rolling 07-19-2020
Department of the Army Broad Agency Announcement (BAA) Supporting Research For The U.S. Department Of Health And Human Services Under Contracts, Other Transaction Agreements, And Technology Investment Agreements For The Treatment And Protection From COVID-19 08-01-2022 07-30-2020
Department of Commerce EDA-HDQ-OIE-2020-2006705 FY 2020 SPRINT Challenge 12-03-2020 10-22-2020
Department of Defense Prototype development of a COVID-19 Pandemic Therapeutic Rapid Advanced Research and Development (ARD) to Large Scale Manufacturing 02-28-2021 07-30-2020
Department of Health and Human Services RFA-IP-21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children 02-08-2021 11-17-2020
Department of Labor Employment and Training Administration ETA-TEGL-12-19 National Dislocated Worker Grants Program  Rolling 03-19-2020
Fast Grants Emergent Ventures: Fast Funding for COVID-19 Science Rolling/Ongoing 04-08-2020
Bill & Melinda Gates Foundation Grand Challenges ICODA COVID-19 Data Science 01-19-21 12-17-2020
House Appropriations  H.R. 6074 CORONAVIRUS PREPAREDNESS AND RESPONSE SUPPLEMENTAL APPROPRIATIONS ACT, 2020 X 03-06-2020
Medical Technology Enterprise Consortium (MTEC) Update on DoD Medical R&D Funding from CARES/COVID-19 Various 04-30-2020
Medical Technology Enterprise Consortium (MTEC) Pre-Announcement for MTEC-20-10-COVID19-NETCCN - "National Emergency Telecritical Care Network (NETCCN) Project" X 03-20-2020
Medical Technology Enterprise Consortium (MTEC) Potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19) X 03-16-2020
NASA

Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 pandemic

Rolling 03-27-2020
National Cancer Institute NOT-CA-21-009 Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported PDX Development and Trial Centers Research Network (PDXNet) 01-08-2021 11-23-2017
National Cancer Institute NOT-CA-20-054 Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis N/A 04-28-2020
National Center for Advancing Translational Sciences (NCATS) NOT-TR-21-012 Notice of NCATS Withdrawal from Participation in PAR-20-243, "Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)"   01/04/2021
National Center for Advancing Translational Sciences (NCATS)

NOT-TR-21-011 Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs

  • Applications will be accepted immediately and on a rolling basis through June 1, 2021 by 5:00 PM local time
06-01-2021 12-18-2020
National Center for Advancing Translational Sciences (NCATS) NOT-TR-20-016 Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Rolling through 01-26-2022 04-09-2020
National Institute on Alcohol Abuse and Alcoholism NOT-AA-20-011 Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA Rolling through 04-15-2021 04-16-2020
National Institute of Allergy and Infectious Diseases (NIAID) NOT-AI-20-063 Notice of Expiration of PAR-20-177 " Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)" Rolling 04-30-2020
National Institute of Allergy and Infectious Diseases (NIAID) NOT-AI-20-062 Notice of Expiration of PAR-20-178 "Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)" Rolling 04-30-2020
National Institute of Allergy and Infectious Diseases (NIAID) PAR-20-177 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Rolling 04-30-2020
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NOT-AR-21-012 Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases 11-18-2021 01-08-2021
National Institute of Biomedical Imaging and Biomedical Engineering NIH POCTRN Fast-Track Program for COVID-19 Test Development and Distribution Rolling 05-15-2020
National Institute of Child Health and Human Development (NICHD) Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)" N/A 06-05-2020
National Institute of Diabetes and Digestive and Kidney Diseases  NOT-DK-20-026 Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK" N/A 04-27-2020
National Institute on Drug Abuse (NIDA) NOT-DA-20-084 Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
This notice applies to due dates on or after January 7, 2021 and subsequent receipt dates through September 8, 2024. 
12-30-2020 10-27-2020
National Institute of Environmental Health Sciences (NIEHS) NOT-ES-21-002 Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities   12-17-2020
National Institute of General Medical Sciences NOT-GM-20-025 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 02-05-2021 03-25-2020
National Institute of Neurological Disorders and Stroke NOT-NS-20-074 Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System" N/A 05-27-2020
National Institute of Neurological Disorders and Stroke NOT-NS-20-051 Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System 04-14-2021 04-30-2020
National Institute on Deafness and Other Communication Disorders (NIDCD) NOT-DC-20-006 Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19 N/A 04-202-2020
NIH NOT-OD-21-035 Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad) 12-04-2020 12-01-2020
NIH NOT-ES-20-020 Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) 05-04-21 04-10-2020
NIH NOT-TR-21-006 Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Expires March 17, 2021 10-24-2020
NIH NOT-HD-20-031 Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic Expires 05-08-2023 10-02-2020
NIH NOT-NS-21-004 Notice of Temporary Extension of Eligibility for the BRAIN Initiative Diversity K99/R00 Career Transition Award During the COVID-19 Pandemic Various through Nov 2021 10-02-2020
NIH NOT-OD-20-179 Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils   10-02-2020
NIH

PAR-20-312 State Occupational Safety and Health Surveillance Program (U60)

Letter of Intent Due Date(s): 10-20-2020, 08-10-2021, 8-10-2022
Application Due Date(s): 12-16-2020, 09-14-2021, 09-14-2022


 
09-29-2020
NIH NOT-OD-20-168 Notice of Change: Expansion of Research Scope of RFA-OD-19-029 “The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)" 11-26-2021 09-15-2020
NIH Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed) 06-18-2021 09-10-2020
NIH RFA-AT-21-003 NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed) 12-18-2020 09-04-2020
NIH PAR-20-302 Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) 12-12-2020 09-04-2020
NIH PAR-20-303 Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) 12-12-2020 09-04-2020
NIH PAR-20-238 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) 04-17-2021 08-17-2020
NIH RFA-TR-20-003 Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) Rolling through 01-24-2021 08-10-2020
NIH NOT-OD-20-156 Notice of Change to Funding Announcement (NOT-OD-20-048) by the Office of Research on Women's Health (ORWH), " Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)" 01-21-2021 08-05-2020
NIH NIAID Refines Objectives by Replacing COVID-19 Competitive Revision NOSI Rolling through 07-02-2021 07-15-2020
NIH New Emergency Opportunity Funds PPE for COVID-19 Clinical Research Rolling until 07-28-2021 07-15-2020
NIH PAR-20-256 Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Rolling 07-13-2020
NIH NOT-AI-20-059 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Rolling until 07-02-2021 07-06-2020
NIH PAR-20-243 Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

12-02-2020
03-02-2021

06-30-2020
NIH NOT-OD-20-129 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project 07-13-2021 06-30-2020
NIH NOT-NS-20-076 Notice to Extend Eligibility for Submission of Diversity K22 Applications due to COVID–related Disruptions N/A 06-29-2020
NIH PAR-20-234 NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
January 4, 2021; and February 1, 2021
Various 06-16-2020
NIH NOT-NS-20-051 Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System 04-15-2021 04-30-2020
NIH NOT-OD-20-097 Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences 03-31-2021 04-13-2020
NIH Updates on NIAID Funding for SARS-CoV-2 and COVID-2019 Research Various 04-01-2020
NIH NOT-HS-20-007 Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19  N/A 03-26-2020
NIH NOT-HS-20-008 Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19  N/A 03-26-2020
NIH  NOT-GM-20-025 Urgent Competitive Revisions to NIGMS Grants to Address the Coronavirus Pandemic 02-05-2021 03-25-2020
NIH  NOT-DA-20-047 Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 03-31-2021 03-19-2020
NIH PA-20-135  Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
NOT-NR-20-005 Notice of Participation of National Institute of Nursing Research (NINR) in PA-20-135 
Ongoing 03-10-2020
NSF NSF 20-105 Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) N/A 07-15-2020
NSF Impact on Existing Deadline Dates 
  • ADVANCE Adaptation and Partnership Tracks: LOIs extended to November 3, 2020; Full proposals: February 4, 2021
  06-19-2020
Oak Ridge National Laboratory Rapid Access Proposal for COVID-19 Research Rolling 04-08-2020
PCORI  Phased Large Awards for Comparative Effectiveness Research – Cycle 3 2020  01-12-2021 03-27-2020
Remade Institute Pandemic Response Funding Opportunity Rolling 04-10-2020
Space Telescope Science Institute COVID-19 – Temporary Eligibility Waiver for STScI Grants In effect through December 31, 2020   09-01-2020
Xsede  COVID-19 High Performance Computing Consortium Rolling 03-24-2020
United Nations COVID-19 Detect and Protect Challenge Rolling through the end of 2020 05-26-2020
US Economic Development Administration

EDA CARES Act Recovery Assistance

Rolling 05-07-2020
USDA The Business and Industry Coronavirus Aid, Relief, and Economic Security Act (CARES Act) Guaranteed Loan Program 09-25-2021 05-22-2020